lundbeck ceo:Lundbeck Announces CEO Succession Plan
Lundbeck Announces CEO Succession Plan
2023年6月27日—Lundbeck,abiopharmaceuticalcompany,hasannouncedtheupcomingretirementofCEODeborahDunsire.Inherplace,theboardofdirectors ...。其他文章還包含有:「CharlvanZyl」、「Executivemanagement」、「LundbeckCEOeyesdealstobolsterpipeline」、「LundbeckCEO」、「LundbeckhiresUCBneurologyexecasnewCEO」、「Ourleadership」、「TheBoardofDirectorsinitiatesCEOsuccession」
查看更多 離開網站Charl van Zyl
https://be.linkedin.com
Experience: Lundbeck · Location: Brussels, Brussels ... During Charl's brief tenure as CEO, JADO reached ... Lundbeck today announced the… Liked by Charl van ...
Executive management
https://www.lundbeck.com
Charl van Zyl joined Lundbeck as President & CEO in September 2023. He brings more than 23 years of experience from commercial international management roles ...
Lundbeck CEO eyes deals to bolster pipeline
https://www.fiercepharma.com
Lundbeck's Charl van Zyl has about 100 days under his belt as the company's new CEO.
Lundbeck CEO
https://www.linkedin.com
Charl van Zyl, who last year took over as CEO of Lundbeck - one of the few pharmaceutical companies with a dedicated focus on diseases ...
Lundbeck hires UCB neurology exec as new CEO
https://www.fiercepharma.com
Lundbeck has tapped Charl van Zyl, head of neurology solutions at UCB, to be its new CEO as Deborah Dunsire retires after hitting record ...
Our leadership
https://www.lundbeck.com
Lundbeck's Executive Management team consists of eight members, led by Charl van Zyl, President & CEO. meet executive management. These twelve members ...
The Board of Directors initiates CEO succession
https://newsroom.lundbeckus.co
The Board of Directors has appointed Charl van Zyl as new President and CEO of Lundbeck. Deborah Dunsire will continue to serve as President and ...